|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 72.47 USD | +1.74% |
|
-3.69% | +9.19% |
| 17/06 | AI Can Play 'Significant' Role in Tech for Managing Diabetes, Says David Roman | MT |
| 15/06 | Piper Sandler Adjusts Price Target on DexCom to $88 From $75, Maintains Overweight Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Medical Equipment, Supplies & Distribution
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 27.96B | |||||
| 154B | |||||
| 102B | |||||
| 59.25B | |||||
| 52.89B | |||||
| 39.67B |
- Stock Market
- Stocks
- DXCM Stock
- Charts DexCom, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
